Sandra Horning

Sandra Horning is a declared insider at 4 companies (board member); the most frequent names are Revolution Medicines, Inc., Gilead Sciences, Inc. and Moderna, Inc. Between 17 December 2021 and 26 June 2025, the trades on record add up to 12 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 30 June 2025, the filings show a share grant in Revolution Medicines, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.